Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy
Open accessPublished version of a preprint
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index; 26 of the 50 sources its claims cite were checked for support.
Abstract
Pulmonary fibrosis is an often fatal lung disease. Immune cells such as macrophages were shown to accumulate in the fibrotic lung, but their contribution to the fibrosis development is unclear. To recapitulate the involvement of macrophages in the development of pulmonary fibrosis, we developed a fibrotic microtissue model with cocultured human macrophages and fibroblasts. We show that profibrotic macrophages seeded on topographically controlled stromal tissues became mechanically activated. The resulting co-alignment of macrophages, collagen fibers, and fibroblasts promoted widespread fibrogenesis in micro-engineered lung tissues. Anti-fibrosis treatment using pirfenidone disrupts the polarization and mechanical activation of profibrotic macrophages, leading to fibrosis inhibition. Pirfenidone inhibits the mechanical activation of macrophages by suppressing integrin αMβ2 and Rho-associated kinase 2. These results demonstrate a potential pulmonary fibrogenesis mechanism at the tissue level contributed by macrophages. The cocultured microtissue model is a powerful tool to study the immune–stromal cell interactions and the anti-fibrosis drug mechanism.
Overview
CoChat Summary
TL;DR
The paper develops a micropillar-based coculture model of human macrophages and lung fibroblasts to show that profibrotic M2 macrophages become mechanically activated, align with collagen fibers and fibroblasts, and drive fibrogenesis. Pirfenidone inhibits this process by suppressing ROCK2 and integrin αMβ2, suggesting a macrophage-targeted anti-fibrosis mechanism.
Key findings
- In human IPF lung tissue, CD206+ macrophages and α-SMA+ myofibroblasts were elongated and aligned; scRNA-seq reanalysis found 28 of 224 mechanotransduction genes up-regulated in IPF macrophages versus healthy donors, enriched for cell-matrix adhesion, integrin-mediated signaling, and cell motility.
- In engineered microtissues, M2 macrophage coculture increased α-SMA expression 4.7-fold versus NHLF-only microtissues and generated 5.7 times higher contractile force than NHLF monocultures; active TGF-β was also higher in coculture supernatant.
- Preventative pirfenidone (10 and 1000 μg/ml) reduced macrophage adhesion by 50 and 86% and α-SMA by 80 and 95%; therapeutic pirfenidone reduced macrophage adhesion by 40% and α-SMA by 47.5% but did not significantly change contractile force.
- Pirfenidone pretreatment reduced macrophage adhesion by 59 and 72%, α-SMA by 80 and 93%, contractile force by 100% at both doses, and active TGF-β by 35 and 50%; pirfenidone suppressed ROCK2 (65 and 74% in preventative/therapeutic regimens) and integrin αM/β2 (64 and 83% in preventative/pretreatment regimens), similar to the ROCK2 inhibitor KD025.
Methods
- Design: in vitro engineered fibrotic microtissue model with cocultured human monocyte-derived M2 macrophages and normal human lung fibroblasts (NHLFs), plus histological and single-cell RNA-seq reanalysis of human IPF lung samples.
- Data/sample: human IPF lung tissue sections; NCBI GEO datasets GSE122960 and GSE228232 (Fig. 1D shows healthy subjects n = 8 and IPF patients n = 4 for GSE122960); peripheral blood monocytes; NHLFs; micropillar arrays in spiral, diamond, and square patterns; M2:NHLF ratio 4:1; 3-day coculture.
- Analysis: immunofluorescence, confocal and scanning electron microscopy, micropillar deflection force measurement, TMLC reporter assay for active TGF-β, and ANOVA with Tukey tests or two-tailed paired Student’s t tests; pirfenidone and KD025 were tested in preventative, therapeutic, and pretreatment regimens.
Limitations
- Stated: the authors note that further histological and single-cell studies on pirfenidone-treated donor lung samples are needed to determine the clinical relevancy of the ROCK2/integrin finding; they also acknowledge that in vitro CD206+ macrophages are simplified relative to the complex in vivo activation spectrum.
- Evident: the model is entirely in vitro (human monocyte-derived M2 macrophages plus NHLFs in engineered collagen microtissues), so it cannot establish causality or efficacy in intact lung; no in vivo animal or human treatment validation is reported.
- Evident: pirfenidone was tested at 10 and 1000 μg/ml, while the paper states the clinical serum concentration is around 10 μg/ml, so the 1000 μg/ml results are supraphysiological.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
14 Valid · 3 Not valid · 12 Not checked · 85 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“In general, macrophages attaching to soft materials exhibit reduced activation into profibrotic M2 macrophages compared to those grown on stiffer substrates (44–48).”
§ Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy > DISCUSSION
What the sources say
- Not checked yetcites [44] E. F. Irwin, K. Saha, M. Rosenbluth, L. J. Gamble, D. G. Castner, K. E. Healy, Modulus-dependent macrophage adhesion and behavior. J. Biomater. Sci. Polym. Ed. 19, 1363– 1382 (2008). 18854128 source
- Not checked yetcites [45] K. M. Adlerz, H. Aranda-Espinoza, H. N. Hayenga, Substrate elasticity regulates the behavior of human monocyte-derived macrophages. Eur. Biophys. J. 45, 301– 309 (2016). 26613613 source
- Disputedcites [46] A. K. Blakney, M. D. Swartzlander, S. J. Bryant, The effects of substrate stiffness on the in vitro activation of macrophages and in vivo host response to poly(ethylene glycol)-based hydrogels. J. Biomed. Mater. Res. A 100, 1375– 1386 (2012). 22407522 PMC3339197 sourceExperimental — accuracy not yet measured
Our copy reports the opposite direction for the wound-healing/alternatively-activated arm: the DISCUSSION concludes that 'softer substrates help to reduce the classically activated macrophage phenotype and shift to a wound healing phenotype', and that on the softest (130 kPa) gel Arginase I (the wound-healing/collagen-precursor marker) was significantly higher at 24 h than on the 840 kPa gel. The paper's reduced-activation effect on soft substrates is a reduction of the pro-inflammatory/classical (M1-type) phenotype — IL-1β and IL-6 were lowest at 130 kPa, while IL-10 rose with increasing stiffness — not a reduction of M2/profibrotic activation. The source also never uses M1/M2 or 'profibrotic' terminology, and its activation comparisons were made in a LPS-simulated inflammatory environment on PEG-RGD hydrogels of 130/240/840 kPa. (LLM, conf=0.72)
Checked by a reasoning model — may be wrong.
- Not checked yetcites [47] S. Fereol, R. Fodil, B. Labat, S. Galiacy, V. M. Laurent, B. Louis, D. Isabey, E. Planus, Sensitivity of alveolar macrophages to substrate mechanical and adhesive properties. Cell Motil. Cytoskeleton 63, 321– 340 (2006). 16634082 source
- Supportedcites [48] R. A. Scott, K. L. Kiick, R. E. Akins, Substrate stiffness directs the phenotype and polarization state of cord blood derived macrophages. Acta Biomater. 122, 220– 235 (2021). 33359292 PMC7904389 source
The Discussion states that 'promotion of M2 phenotypes in CB-derived macrophages was induced by increased matrix stiffness, with M2c phenotypes (elevated CD163+) predominating on substrates with intermediate stiffness and M2a phenotypes (elevated CD206+) predominating on the stiffest substrates' — i.e., soft substrates gave reduced M2 activation. The Results ('Hydrogel Stiffness Regulates Macrophage Phenotype') back this quantitatively: CD206+ 63.3 ± 3.0% on 14wt% versus 23 ± 6% on soft 3wt%, with the M2a/profibrotic growth factors TGF-β1 (1947 vs 1240 pg/10^5 cells) and PDGF-BB (152 vs 108) and MMP-9 (5488 vs 680) elevated on the stiffest hydrogel. The paper does not use the word 'profibrotic' itself but ties the stiff-substrate M2a phenotype to TGF-β1/PDGF-BB, so the descriptor is a fair paraphrase; the supporting data come from cord blood-derived macrophages on PEG hydrogels of 0.1–10.3 kPa shear modulus, and the same passage notes hybrid phenotypes with raised M1 cytokines (IL-6, TNF-α) on the stiffest substrate. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the fibrotic lung tissue, the excessively accumulated fibrillar collagen is often aligned in dense bundles, as a result of the active extracellular matrix (ECM) remodeling by contractile myofibroblasts (17).”
§ Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy > INTRODUCTION
What the sources say
- Partly supportedcites [17] A. J. Haak, Q. Tan, D. J. Tschumperlin, Matrix biomechanics and dynamics in pulmonary fibrosis. Matrix Biol. 73, 64– 76 (2018). 29274939 PMC6013326 sourceExperimental — accuracy not yet measured
Our copy supports the background halves of the claim: 'Fibrillar collagen deposition is the dominant architectural feature of human lung fibrosis' (Pulmonary Fibrosis Effects on ECM Composition) and 'pulmonary fibrosis is associated with aberrant deposition of fibrillar collagens' (How might ECM mechanics and composition be restored?), together with matrix stiffness-sensitive activation of fibroblasts 'to a contractile, proliferative and matrix synthetic state' and 'Myofibroblast contractility can further amplify cellular activation...' (How Do ECM Alterations Contribute to IPF Progression?). What it does not support is the distinctive architectural/mechanical assertion: no passage in our copy describes the accumulated fibrillar collagen as being 'aligned in dense bundles', nor attributes such alignment or fiber reorientation to the contractile force of myofibroblasts — the only organized-bundle statements concern normal lung (bands of collagen and elastin in alveolar ducts, organized collagen/elastin in airways and vessels; Homeostasis in Lung Extracellular Matrix Composition and Mechanics). The source's ECM remodeling is discussed as proteolysis/cross-linking (MMP14, cathepsin K, LOX/LOXL2), not as contractile bundling, so the causal link the citing sentence asserts is not this paper's. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This pathologically stiff tissue microenvironment also provides topographic cues to the embedded cells, causing changes in the cellular functions such as their morphology and alignment (18, 19).”
§ Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy > INTRODUCTION
What the sources say
- Partly supportedcites [18] S. Adams, L. M. Wuescher, R. Worth, E. Yildirim-Ayan, Mechano-immunomodulation: Mechanoresponsive changes in macrophage activity and polarization. Ann. Biomed. Eng. 47, 2213– 2231 (2019). 31218484 PMC7043232 sourceExperimental — accuracy not yet measured
Our copy supports only part of what is attributed: in 'The Intertwined Concepts of Tissue Engineering and the Innate Immune Response' it states that a biomaterial's physical properties — surface topography, roughness and stiffness — modulate macrophage responses, and that topographical patterns (0.15–50 μm) produced elongation, i.e. a morphological change. However, the cues it describes come from implanted scaffolds/biomaterial substrates, not from a 'pathologically stiff tissue microenvironment'; the paper explicitly defers tissue stiffness and disease progression to other in-depth reviews, and its stiffness section reports conflicting M1/M2 results rather than a pathological-stiffness effect. No passage in our copy reports cell alignment as an outcome of topographic or stiffness cues, so that element of the claim is unsupported. (LLM, conf=0.68)
- Not checked yetcites [19] N. Jain, J. Moeller, V. Vogel, Mechanobiology of macrophages: How physical factors coregulate macrophage plasticity and phagocytosis. Annu. Rev. Biomed. Eng. 21, 267– 297 (2019). 31167103 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies suggest that the latter effect is at least in part due to the contribution of pro-fibrotic macrophages to the activation of fibroblasts into to myofibroblasts in a process that depends on physical contact (14, 15).”
§ Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy > INTRODUCTION
What the sources say
- Partly supportedcites [14] A. V. Misharin, L. Morales-Nebreda, P. A. Reyfman, C. M. Cuda, J. M. Walter, A. C. McQuattie-Pimentel, C.-I. Chen, K. R. Anekalla, N. Joshi, K. J. N. Williams, H. Abdala-Valencia, T. J. Yacoub, M. Chi, S. Chiu, F. J. Gonzalez-Gonzalez, K. Gates, A. P. Lam, T. T. Nicholson, P. J. Homan, S. Soberanes, S. Dominguez, V. K. Morgan, R. Saber, A. Shaffer, M. Hinchcliff, S. A. Marshall, A. Bharat, S. Berdnikovs, S. M. Bhorade, E. T. Bartom, R. I. Morimoto, W. E. Balch, J. I. Sznajder, N. S. Chandel, G. M. Mutlu, M. Jain, C. J. Gottardi, B. D. Singer, K. M. Ridge, N. Bagheri, A. Shilatifard, G. R. S. B sourceExperimental — accuracy not yet measured
Our copy supports only the first half of the attributed idea: the Results (cluster III / Fig. 6) and Discussion show that monocyte-derived alveolar macrophages (Mo-AMs) carrying a profibrotic transcriptional signature are causally required for bleomycin- and Ad-TGF-β–induced lung fibrosis, and that their human homologues are up-regulated in alveolar macrophages from fibrotic explants (Fig. 8 D). Nothing in our copy states that these macrophages activate fibroblasts into myofibroblasts or that the process depends on physical cell-cell contact — searches for 'myofibroblasts', 'cell-cell contact', 'co-culture', and 'fibroblast activation' returned no such passage; the paper's mechanism is paracrine profibrotic gene products (e.g., Pdgfa, Mmp12/13/14, Tgfβ1), and it explicitly argues against the M2 'polarization' explanation (Results, Fig. 6 F). The contact-dependent myofibroblast-activation component therefore rests on the other citation, not on this source. (LLM, conf=0.70)
- Not checked yetcites [15] M. Lodyga, E. Cambridge, H. M. Karvonen, P. Pakshir, B. Wu, S. Boo, M. Kiebalo, R. Kaarteenaho, M. Glogauer, M. Kapoor, K. Ask, B. Hinz, Cadherin-11–mediated adhesion of macrophages to myofibroblasts establishes a profibrotic niche of active TGF-β. Sci. Signal. 12, eaao3469 (2019). 30647145 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“It is noteworthy that the serum PFD concentration in the clinical setting is around 10 μg/ml (33).”
§ Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy > RESULTS > Anti-fibrosis treatment with PFD acts on macrophage-induced fibrosis
What the sources say
- Could not verifycites [33] L. Richeldi, S. Fletcher, H. Adamali, N. Chaudhuri, S. Wiebe, S. Wind, K. Hohl, A. Baker, R. Schlenker-Herceg, S. Stowasser, T. M. Maher, No relevant pharmacokinetic drug–drug interaction between nintedanib and pirfenidone. Eur. Respir. J. 53, 1801060 (2019). 30442716 sourceExperimental — accuracy not yet measured
Our copy of Richeldi et al. reports pirfenidone pharmacokinetics only as relative exposure: the Pharmacokinetics of pirfenidone section gives adjusted gMean ratios of 97.2% (AUCτ,ss) and 99.5% (Cmax,ss) with 90% CIs of 88–108% and 88–113%, and refers the absolute values to table 3, whose numeric rows are not present in our indexed text. Searches for an absolute pirfenidone concentration ('pirfenidone Cmax,ss/AUCτ,ss table 3 values', 'plasma concentration 10 µg/mL', 'clinical dose trough concentration') returned no statement of a ~10 μg/mL level; the only concentration figures are the assay calibration range of 100–50,000 ng·mL⁻¹ (Pharmacokinetic evaluation) and nintedanib values in ng·mL⁻¹ (table 2). Moreover, the source measured plasma in a crossover trial in IPF patients on 801 mg t.i.d., not 'serum concentration in the clinical setting' as a general statement, so the claim's magnitude and generalisation cannot be checked against our copy. (LLM, conf=0.65)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
66 more claims · 8 with their cited sources checked
Create a free account to see all 114 claims and to verify the 24 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 36
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“M2 macrophages secrete TGF-b1, which can activate fibroblasts to produce LOX, thereby promoting collagen crosslinking and matrix stiffening (68).”
From The mechanotransduction-immune axis in organ fibrosis: dual regulatory mechanisms and translational therapeutic perspectives (2025) · doi:10.3389/fimmu.2025.1670213 · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy > DISCUSSION
“IL-3/IL-14–polarized M2a macrophages seeded in pure collagen matrix were not able to generate sufficient contractile force to compact the collagen matrix and form a microtissue (fig. S5B)”
§ Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy > MATERIALS AND METHODS > Peripheral blood monocyte isolation and pro-fibrotic macrophage differentiation
“mature macrophages were polarized by adding IL-4 (20 ng/ml; A42602, Invitrogen) and IL-13 (20 ng/ml; Invitrogen, A42526) to generate M2 macrophages for an additional 24 hours.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy > RESULTS > Lung macrophages undergo mechanical activation in fibroblast-remodeled fibrotic tissue microenvironment
“Data extracted from healthy subjects (n = 8) and patients with IPF (n = 4) based on NCBI GEO dataset GSE122960.”
§ Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy > MATERIALS AND METHODS > Single-cell RNA-seq data mining
“For the generation of t-distributed stochastic neighbor embedding (t-SNE) plots for alveolar macrophages (Fig. 1, C and D), cells identified as macrophages through individual annotation of single-cell RNA-seq data from eight normal lungs and eight fibrotic lungs were aggregated.”
Citations
Cites
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337 · cited 1×
“For simplicity, in vitro–generated CD206-positive macrophages are often called M2 phenotypes, recognizing that macrophages exist in a more complex polarization (activation) spectrum in vivo ( 5 , 14 , 21 – 25 ).”
BackgroundFibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868 · cited 1×
“Their involvement in fibrogenesis makes immune cells attractive targets for anti-fibrosis therapies ( 26 ).”
BackgroundSelective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 1×
“The absence of macrophages during inflammation has been shown to result in impaired wound healing ( 9 , 10 ), while macrophage persistence beyond acute repair phases can result in organ fibrosis ( 11 – 13 ).”
Modulation of macrophage phenotype by cell shape
McWhorter, F. Y., Wang, T., Nguyen, P., Chung, T., & Liu, W. F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308887110 · Cited by 1,482 · cited 3×
“M2 macrophages have been shown to align on the microgrooves created on 2D elastic substrate ( 20 ).”
BackgroundAdams, T. S., Schupp, J. C., Poli, S., Ayaub, E. A., Neumark, N., Ahangari, F., Chu, S. G., Raby, B. A., DeIuliis, G., Januszyk, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1983 · Cited by 1,420
Martinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Inflammation and metabolism in tissue repair and regeneration
Eming, S. A., Wynn, T. A., & Martin, P. (2017) · Science · doi:10.1126/science.aam7928 · Cited by 1,369 · cited 1×
“For instance, macrophages can either contribute to normal repair or attain pro-fibrotic roles, depending on timing, context, and their activation status ( 7 , 8 ).”
BackgroundReyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203 · cited 6×
“1C) ( 31 ).”
InfluentialMonocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162152 · Cited by 1,133 · cited 2×
“For simplicity, in vitro–generated CD206-positive macrophages are often called M2 phenotypes, recognizing that macrophages exist in a more complex polarization (activation) spectrum in vivo ( 5 , 14 , 21 – 25 ).”
BackgroundRamachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001
Cited by
Ezzo, M., Spindler, K., Wang, J. B., Lee, D., Pecoraro, G., Cowen, J., Pakshir, P., & Hinz, B. (2024) · Science Advances · doi:10.1126/sciadv.adp4726 · Cited by 82
“Our own studies suggest that proximity to M ϕ is critical for myofibroblast activation over several days of coculture ( 9 , 19 ).”
BackgroundSelf-citationXiong, J., Xiao, R., Zhao, J., Zhao, Q., Luo, M., Li, F., Zhang, W., & Wu, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04810-3 · Cited by 79
Xie, W., Yu, X., Yang, Q., Ke, N., Wang, P., Kong, H., Wu, X., Ma, P., Chen, L., Yang, J., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1712 · Cited by 59
Hou, F., Shi, N., Yuan, H., LI, B. C., Xiao, J., Xiao, K., & Xie, L. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00750-6 · Cited by 46
(2025) · doi:10.3389/fimmu.2025.1670213 · Cited by 29
Metadata
- Authors
- Xu, Y., Ying, L., Lang, J. K., Hinz, B., & Zhao, R.
- Affiliations
- University at Buffalo, State University of New York (US)
- VA Western New York Healthcare System (US)
- St. Michael's Hospital (CA)
- Corresponding author
- Zhao, Ruogang
- Venue
- Science Advances
- Published
- 2024-03-29
- Volume
- 10
- Issue
- 13
- Pages
- eadj9559-eadj9559
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC10980276
- OpenAlex
- W4393319429
- Cited by
- 67
- References
- 62
- Citations by year
- 2026: 33 · 2025: 31 · 2024: 3
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- York University
- National Institutes of Health
- University at Buffalo
- NYU Grossman School of Medicine
- Canadian Institutes of Health Research (375597)
- National Heart, Lung, and Blood Institute (R33HL154117, R01HL163428)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- pulmonary fibrosis, macrophages, mechanical activation, fibrogenesis, macrophage polarization, pirfenidone, Mac-1, collagen fiber alignment, antifibrotic therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.